LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE864.251.05 (+0.12 %)
PREV CLOSE ( ) 863.20
OPEN PRICE ( ) 864.00
BID PRICE (QTY) 864.25 (50)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33728
TODAY'S LOW / HIGH ( )860.00 873.10
52 WK LOW / HIGH ( )723.55 986
NSE864.60-0.85 (-0.1 %)
PREV CLOSE( ) 865.45
OPEN PRICE ( ) 866.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 864.60 (951)
VOLUME 837289
TODAY'S LOW / HIGH( ) 859.25 873.60
52 WK LOW / HIGH ( )723.65 986.1
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
23Jan Lupin informs about board meeting
Pursuant to Regulation 29(1) (a) of the SEBI (Listing Obligations and Di..
23Jan Lupin informs about allotment of equit
Lupin has informed that the Allotment Committee of Directors at its meet..
22Jan Inflame Appliances, Lupin and IDBI Ban
Inflame Appliances has set up a new facility to produce Electrical Chimn..
22Jan Lupin slips on the bourses
Lupin is currently trading at Rs. 863.00, down by 2.50 points or 0.29% f..
21Jan Lupin recalling anti-bacterial drug Ce
Lupin is voluntarily recalling 55,000 vials and 1,60,241 boxes of anti-b..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit4247.513446.6
Gross Profit 5801.8 17939.3
Operating Profit 6950.522169.8
Net Sales 27125.5100881.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 1650.90 (2.65%)
M.Cap (Rs. in Cr)4127.25
Piramal Enterprises (BSE)
 2360.25 (1.09%)
M.Cap (Rs. in Cr)43333.78
Fredun Pharma (BSE)
 400.30 (5.91%)
M.Cap (Rs. in Cr)159.71
TTK Healthcare (BSE)
 770.30 (2.03%)
M.Cap (Rs. in Cr)1088.46
Sun Pharma Inds. (BSE)
 430.75 (3.04%)
M.Cap (Rs. in Cr)103351.07
Shareholding Pattern
PROMOTERS 46.98%
NON-INSTITUTION 14.18%
MUTUAL FUNDS/UTI 5.69%
FI/BANKS/INSURANCE 5.38%
GOVERNMENT 0.27%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.